Published in J Immunol on December 15, 1997
Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol (2009) 2.48
Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun (2010) 1.01
Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis. Arthritis Res Ther (2008) 0.96
Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin. Viruses (2015) 0.91
IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway. PLoS One (2011) 0.90
Molecular blocking of CD23 supports its role in the pathogenesis of arthritis. PLoS One (2009) 0.85
CD23 mediates antimycobacterial activity of human macrophages. Infect Immun (2009) 0.82
The effect of conventional and mini-invasive cardiopulmonary bypass on neutrophil activation in patients undergoing coronary artery bypass grafting. Mediators Inflamm (2012) 0.80
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science (1997) 10.35
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (1987) 4.96
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT). J Exp Med (1975) 3.17
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med (1998) 2.99
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood (2001) 2.87
Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. J Exp Med (1975) 2.78
Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med (1992) 2.54
Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide. J Exp Med (1976) 2.39
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol (2012) 1.99
Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol (1995) 1.98
The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A (1995) 1.88
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol (2003) 1.86
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Eur J Immunol (1990) 1.75
The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg (2004) 1.72
Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest (1995) 1.70
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant Rev (1975) 1.64
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol (2000) 1.62
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci (1999) 1.58
Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT). J Exp Med (1976) 1.57
Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56
Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48
Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS (1999) 1.47
Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol (1990) 1.47
Ginseng as a cause for Stevens-Johnson syndrome? Lancet (1996) 1.46
Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol (1997) 1.46
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol (1996) 1.43
[Scabies finally getting the attention it merits!]. Ann Dermatol Venereol (2012) 1.43
Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis. Br J Dermatol (1994) 1.42
Hypochromic vitiligo: delineation of a new entity. Br J Dermatol (2014) 1.42
Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol (1996) 1.40
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups. J Immunol (2000) 1.39
[Effects of postoperative autotransfusion in prosthetic surgery of the hip with the ConstaVac device]. Ann Fr Anesth Reanim (1993) 1.39
[Etiology of ecthyma gangrenosum: four cases]. Ann Dermatol Venereol (2010) 1.39
Hypothermia related to air-fluidized bed. Intensive Care Med (1991) 1.39
[Treatment of seborrheic dermatitis]. Ann Dermatol Venereol (2004) 1.39
[Effects of platelet-rich plasma on hemostasis and transfusion requirement in vascular surgery]. Ann Fr Anesth Reanim (1995) 1.39
[Dermatology day-care: between official rules and reality]. Ann Dermatol Venereol (2012) 1.38
[Nephrogenic systemic fibrosis]. Ann Dermatol Venereol (2009) 1.37
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood (1999) 1.36
Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis (1996) 1.34
Cutaneous graft-versus-host disease. Arch Dermatol (1998) 1.33
Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol (1998) 1.33
Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol (1995) 1.32
Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. J Clin Invest (1994) 1.29
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
MR imaging in acute infectious cellulitis. Radiology (1994) 1.23
NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases. Cytokine (1991) 1.23
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis (2007) 1.21
Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today (1995) 1.20
Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood (2001) 1.20
Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol (2013) 1.18
Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17
A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol (1991) 1.16
Herpes zoster: Burden of disease in France. Vaccine (2010) 1.15
Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood (1990) 1.15
Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood (1994) 1.15
Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol (2001) 1.12
c-Kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukoc Biol (2000) 1.12
Restoration of the immune system with anti-retroviral therapy. Immunol Lett (1999) 1.12
Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy (2001) 1.11
Insecticide resistance in head lice: clinical, parasitological and genetic aspects. Clin Microbiol Infect (2012) 1.11
Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol (1998) 1.07
IgE-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes: the role of cAMP and nitric oxide. Cell Mol Biol (Noisy-le-grand) (1994) 1.07
[Neglected skin tumors. Three cases]. Ann Dermatol Venereol (2012) 1.07
Genetic control of sensitivity to Moloney-virus-induced leukemias in mice. I. Demonstration of multigenic control. Int J Cancer (1978) 1.06
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06
Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies. Leukemia (2010) 1.06
Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes. Eur J Radiol (1999) 1.05
Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol (2000) 1.05
Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol (1998) 1.05
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS (1999) 1.04
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). I. Production, characterization, and lack of H-2 restriction for activity in recipient strain. J Immunol (1977) 1.04
Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol (2001) 1.03
Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant (2006) 1.03
A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J Immunol (1995) 1.03
Cell calcium signaling via GM1 cell surface gangliosides in the human Jurkat T cell line. J Immunol (1994) 1.03
Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis (2010) 1.02